Internal Medicine, Pulmonary Disease · Cleveland, OH
NPI
1407052632
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9500 Euclid Ave, A 90
Cleveland, OH, 44195
Phone (216) 444-4707
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
272 services
Medicare patients, 2024
121
Average age 71
Drug cost, 2024
$11.0M
1,177 prescriptions
Company payments, 2025
$33K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gustavo A Heresi Davila was code 99233 (hospital e&m - subsequent), 103 times for 39 patients. In total Gustavo A Heresi Davila billed 272 services in 13 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 103 | 39 | $89.27 | $9,195 |
| 99214 Office E&M - Established | Facility | 48 | 39 | $69.00 | $3,312 |
| 99215 Office E&M - Established | Facility | 37 | 29 | $108.67 | $4,021 |
| 99205 Office E&M - New | Facility | 17 | 17 | $123.45 | $2,099 |
| 99239 Hospital Discharge Management | Facility | 12 | 12 | $85.83 | $1,030 |
By year: 2022 $20K for 235 services; 2023 $15K for 168 services; 2024 $25K for 272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gustavo A Heresi Davila prescribed most often to Medicare patients was Adempas (Riociguat), with 310 prescriptions and refills. In total Gustavo A Heresi Davila wrote 1,177 Medicare prescriptions that cost $11.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Adempas Riociguat | 310 | 310 | 33 | $4.3M |
| Uptravi Selexipag | 111 | 111 | 13 | $2.5M |
| Opsumit Macitentan | 110 | 110 | 12 | $1.4M |
| Sildenafil Citrate Generic | 99 | 140 | 18 | $46K |
| Orenitram Er Treprostinil Diolamine | 77 | 77 | Under 11 | $668K |
| Tadalafil Generic | 65 | 65 | Under 11 | $74K |
| Ambrisentan Generic | 64 | 64 | Under 11 | $285K |
| Tyvaso Dpi Treprostinil | 59 | 59 | Under 11 | $1.3M |
| Eliquis Apixaban | 34 | 50 | Under 11 | $30K |
| Furosemide Generic | 28 | 40 | Under 11 | $97 |
| Torsemide Generic | 27 | 51 | Under 11 | $348 |
| Winrevair Sotatercept-Csrk | 20 | 20 | Under 11 | $277K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 16 | 16 | Under 11 | $352 |
| Spironolactone Generic | 16 | 44 | Under 11 | $27.36 |
| Jardiance Empagliflozin | 13 | 37 | Under 11 | $22K |
Brand drugs: 794 claims; generic drugs: 383 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gustavo A Heresi Davila $33K ($33K in general payments such as food, travel and fees) from 4 companies. The largest payer was Merck Sharp & Dohme LLC with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.